ZBIO
Zenas BioPharma, Inc.
27.00$
-2.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | |
| – | 0.2% | 2,782.8% | 0.6% | |
| – | 100.0% | -2,682.8% | 100.0% | |
| – | 120.1% | 2,782.8% | 1,680.6% | |
| – | 34.2% | 577.0% | 533.2% | |
| – | 174.3% | 595.0% | 2,213.9% | |
| – | -74.3% | -3,277.8% | -2,113.9% | |
| – | – | 0.0% | 73.3% | |
| – | -73.6% | -3,131.2% | -3,778.2% | |
| – | 0.6% | 8.6% | -0.8% | |
| – | -74.2% | -3,139.8% | -3,777.4% | |
| – | -54.1% | -3,128.4% | -3,704.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.